In the last 12 months, insiders at InMed Pharmaceuticals Inc. ($INM) filed 52 transactions with the SEC: 2 open-market purchases totaling $29,547 and 1 sales totaling $42. Net insider sentiment: net buying.
InMed Pharmaceuticals Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- ADAMS ERIC A (President & CEO) — 8 transactions totaling $14,922
- HULL ANDREW (Director) — 7 transactions totaling $14,625
- MANCINI ALEXANDRA DIANE JANET (Other) — 1 transaction totaling $42
- Lemerond Nicole (Director) — 3 transactions totaling $0
- Tegge Jonathan (Interim CFO) — 1 transaction totaling $0
View all SEC Filings for InMed Pharmaceuticals Inc. (INM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Jagpal Netta | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 18000 | $0.00 | 24,250.0000 | 3,954,549 | 288.00% | 0.46% |
| Dec. 19, 2025 | Klompas Neil A | Director | A | Employee Stock Option (Right to Buy) | 1750 | $0.00 | 5,250.0000 | 3,954,549 | 50.00% | 0.04% |
| Dec. 19, 2025 | Lemerond Nicole | Director | A | Employee Stock Option (Right to Buy) | 1750 | $0.00 | 2,725.0000 | 3,954,549 | 179.49% | 0.04% |
| Dec. 19, 2025 | Johnson Shane Aaron | Sr VP & General Manager | A | Employee Stock Option (Right to Buy) | 8500 | $0.00 | 12,400.0000 | 3,954,549 | 217.95% | 0.21% |
| Dec. 19, 2025 | HULL ANDREW | Director | A | Employee Stock Option (Right to Buy) | 1750 | $0.00 | 2,711.0000 | 3,954,549 | 182.10% | 0.04% |
| Dec. 19, 2025 | ADAMS ERIC A | President & CEO | A | Employee Stock Option (Right to Buy) | 35000 | $0.00 | 49,050.0000 | 3,954,549 | 249.11% | 0.89% |
| Dec. 19, 2025 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | A | Employee Stock Option (Right to Buy) | 13000 | $0.00 | 18,280.0000 | 3,954,549 | 246.21% | 0.33% |
| Dec. 19, 2025 | Bathery John Steven | Director | A | Employee Stock Option (Right to Buy) | 1750 | $0.00 | 5,250.0000 | 3,954,549 | 50.00% | 0.04% |
| Dec. 19, 2025 | WOUDENBERG MICHAEL | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 18000 | $0.00 | 25,445.0000 | 3,954,549 | 241.77% | 0.46% |
| Dec. 15, 2025 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 70 | $0.00 | 5,280.0000 | 3,954,549 | 1.31% | 0.00% |
| Dec. 15, 2025 | WOUDENBERG MICHAEL | Chief Operating Officer | H | Employee Stock Option (Expiration) | 60 | $0.00 | 7,445.0000 | 3,954,549 | 0.80% | 0.00% |
| Dec. 15, 2025 | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 250 | $0.00 | 14,050.0000 | 3,954,549 | 1.75% | 0.01% |
| Dec. 15, 2025 | HULL ANDREW | Director | H | Employee Stock Option (Expiration) | 14 | $0.00 | 961.0000 | 3,954,549 | 1.44% | 0.00% |
| Oct. 17, 2025 | Klompas Neil A | Director | A | Employee Stock Option (Right to Buy) | 3500 | $0.00 | 3,500.0000 | 3,954,549 | 9999.99% | 0.09% |
| Jan. 11, 2025 | HULL ANDREW | Director | H | Employee Stock Option (Expiration) | 2 | $0.00 | 975.0000 | 706,546 | 0.20% | 0.00% |
| Dec. 20, 2024 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | A | Employee Stock Option (Right to Buy) | 2750 | $0.00 | 5,350.0000 | 620,127 | 105.77% | 0.44% |
| Dec. 20, 2024 | Johnson Shane Aaron | Sr VP & General Manager | A | Employee Stock Option (Right to Buy) | 1500 | $0.00 | 3,900.0000 | 620,127 | 62.50% | 0.24% |
| Dec. 20, 2024 | Jagpal Netta | Chief Financial Officer | A | Employee Stock Option (Right to Buy) | 3750 | $0.00 | 6,250.0000 | 620,127 | 150.00% | 0.60% |
| Dec. 20, 2024 | Lemerond Nicole | Director | A | Employee Stock Option (Right to Buy) | 550 | $0.00 | 975.0000 | 620,127 | 129.41% | 0.09% |
| Dec. 20, 2024 | WOUDENBERG MICHAEL | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 3750 | $0.00 | 7,505.0000 | 620,127 | 99.87% | 0.60% |
| Dec. 20, 2024 | Grove Janet P | Director | A | Employee Stock Option (Right to Buy) | 550 | $0.00 | 975.0000 | 620,127 | 129.41% | 0.09% |
| Dec. 20, 2024 | ADAMS ERIC A | President & CEO | A | Employee Stock Option (Right to Buy) | 6250 | $0.00 | 14,300.0000 | 620,127 | 77.64% | 1.01% |
| Dec. 20, 2024 | Baldasare Bryan T | Director | A | Employee Stock Option (Right to Buy) | 550 | $0.00 | 975.0000 | 620,127 | 129.41% | 0.09% |
| Dec. 20, 2024 | HULL ANDREW | Director | A | Employee Stock Option (Right to Buy) | 550 | $0.00 | 977.0000 | 620,127 | 128.81% | 0.09% |
| July 31, 2024 | MANCINI ALEXANDRA DIANE JANET | Other | S | Common Stock | 240 | $0.18 | 0.0000 | 381,053 | 100.00% | 0.06% |
| May 27, 2024 | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 485 | $0.00 | 52,000.0000 | 480,649 | 0.92% | 0.10% |
| May 27, 2024 | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 1139 | $0.00 | 161,000.0000 | 480,649 | 0.70% | 0.24% |
| May 27, 2024 | WOUDENBERG MICHAEL | Chief Operating Officer | H | Employee Stock Option (Expiration) | 394 | $0.00 | 75,100.0000 | 480,649 | 0.52% | 0.08% |
| May 27, 2024 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 545 | $0.00 | 52,000.0000 | 480,649 | 1.04% | 0.11% |
| Jan. 14, 2024 | HULL ANDREW | Director | H | Employee Stock Option (Expiration) | 42 | $0.00 | 8,542.0000 | 398,673 | 0.49% | 0.01% |
| March 4, 2024 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 309 | $0.00 | 52,545.0000 | 398,673 | 0.58% | 0.08% |
| Jan. 21, 2024 | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 121 | $0.00 | 52,485.0000 | 398,673 | 0.23% | 0.03% |
| Feb. 21, 2024 | HULL ANDREW | Director | P | Common Stock | 37500 | $0.39 | 38,258.0000 | 398,673 | 4947.23% | 9.41% |
| Feb. 20, 2024 | ADAMS ERIC A | President & CEO | P | Common Stock | 41600 | $0.36 | 43,959.0000 | 398,673 | 1763.46% | 10.44% |
| Dec. 23, 2023 | Tegge Jonathan | Interim CFO | A | Employee Stock Option (Right to Buy) | 30000 | $0.00 | 31,400.0000 | 166,410 | 2142.86% | 18.03% |
| Dec. 23, 2023 | Grove Janet P | Director | A | Employee Stock Option (Right to Buy) | 7100 | $0.00 | 8,500.0000 | 166,410 | 507.14% | 4.27% |
| Dec. 23, 2023 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | A | Employee Stock Option (Right to Buy) | 45000 | $0.00 | 52,854.0000 | 166,410 | 572.96% | 27.04% |
| Dec. 23, 2023 | ADAMS ERIC A | President & CEO | A | Employee Stock Option (Right to Buy) | 136000 | $0.00 | 162,139.0000 | 166,410 | 520.30% | 81.73% |
| Dec. 23, 2023 | Baldasare Bryan T | Director | A | Employee Stock Option (Right to Buy) | 7100 | $0.00 | 8,500.0000 | 166,410 | 507.14% | 4.27% |
| Dec. 23, 2023 | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | A | Employee Stock Option (Right to Buy) | 45000 | $0.00 | 52,606.0000 | 166,410 | 591.64% | 27.04% |
| Dec. 23, 2023 | HULL ANDREW | Director | A | Employee Stock Option (Right to Buy) | 7100 | $0.00 | 8,584.0000 | 166,410 | 478.44% | 4.27% |
| Dec. 23, 2023 | WOUDENBERG MICHAEL | Chief Operating Officer | A | Employee Stock Option (Right to Buy) | 65000 | $0.00 | 75,494.0000 | 166,410 | 619.40% | 39.06% |
| Dec. 23, 2023 | Lemerond Nicole | Director | A | Employee Stock Option (Right to Buy) | 7100 | $0.00 | 8,500.0000 | 166,410 | 507.14% | 4.27% |
| Dec. 23, 2023 | Johnson Shane Aaron | Sr VP & General Manager | A | Employee Stock Option (Right to Buy) | 40000 | $0.00 | 48,000.0000 | 166,410 | 500.00% | 24.04% |
| Dec. 5, 2023 | WOUDENBERG MICHAEL | Chief Operating Officer | H | Employee Stock Option (Expiration) | 848 | $0.00 | 10,494.0000 | 166,410 | 7.48% | 0.51% |
| Aug. 31, 2023 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 327 | $0.00 | 7,854.0000 | 2,448,458 | 4.00% | 0.01% |
| May 16, 2023 | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 485 | $0.00 | 7,606.0000 | 3,328,191 | 5.99% | 0.01% |
| May 16, 2023 | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 1818 | $0.00 | 26,139.0000 | 3,328,191 | 6.50% | 0.05% |
| May 16, 2023 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 152 | $0.00 | 8,181.0000 | 3,328,191 | 1.82% | 0.00% |
| March 8, 2023 | HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | H | Employee Stock Option (Expiration) | 545 | $0.00 | 8,333.0000 | 2,300,526 | 6.14% | 0.02% |
| March 8, 2023 | MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | H | Employee Stock Option (Expiration) | 61 | $0.00 | 8,091.0000 | 2,300,526 | 0.75% | 0.00% |
| March 8, 2023 | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 545 | $0.00 | 27,957.0000 | 2,300,526 | 1.91% | 0.02% |